All News

Additionally, the results also showed a 25% reduction in the risk of disease progression or death with durvalumab plus chemotherapy.

This month's products features jelly bean vitamins, nail repair, and Mucinex InstaSoothe.

Stanford Medicine investigators were able to estimate who is most likely to land in the hospital.

Results of an analysis show that 3 doses of either Oxford/AstraZeneca COVID-19 or Pfizer BioNTech COVID-19 neutralizes the variant.

In a presidential advisory, the American Heart Association says that individuals thought to be having an allergic response to the injection may instead by experiencing a cardiac reaction.

Study results demonstrate that ProBiotix’s probiotic strain can significantly reduce low-density lipoprotein levels.

The meta-analysis is the first-of-its-kind phase 3 randomized clinical trial with individual patient data.

Becoming involved in different charitable causes and leadership programs can only benefit pharmacists.

Exederm treats itching, inflammation, redness, and rash associated with eczema and dermatitis.

Lifitegrast ophthalmic solution (Xiidra) 5% is indicated for the treatment of the signs and symptoms of dry eye disease.

Glioblastoma can be very difficult to treat and a cure is often not possible.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discussed inclisiran’s mechanism of action and how it supports LDL-C management for patients with ASCVD.

With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.

Properly implemented CGMP should not be seen as a regulatory burden but a remedy to poorly compounded drugs.

Further, the Index is based on proprietary data from PCR testing services administered by Walgreens.

Clinical benefits were seen across subgroups, including patients with squamous and non-squamous lung cancer subtypes, and regardless of PD-L1 levels.

Shreejit Nair, senior vice president and life sciences market business lead at CitiusTech, discussed what the impact of the pandemic has been on the advancement of data interoperability in health care.

A sizable number of clinical trial participants say they had at least 1 AE, with fatigue and headaches the most common.

The analysis describes cost-effective options for individuals without symptoms and recommends isolation strategies to help policymakers safeguard against resurgences.

Agency aims to allow electronic prescriptions for schedule II to V drugs between registered retail pharmacies on 1-time basis for initial fill.

Finding alternative means to promote interleukin 25 could enhance the benefits of fecal transplants in patients with recurrent C. difficile infections.

Cequa ophthalmic solution is indicated to increase tear production in patients with dry eyes.

Patients with Gilbert's syndrome are born with the condition because of an inherited gene mutation.

Patients can sometimes develop Guillain-Barre syndrome after having a recent respiratory illness or digestive tract infection and, in rare cases, after receiving certain vaccines.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran, discussed the trial results assessing the efficacy and safety of inclisiran for patients with atherosclerotic cardiovascular disease.

Drug shortages, infrastructure and wholesaler challenges will be the backdrops of the pharmacy landscape this year.

Shreejit Nair, senior vice president and life sciences market business lead at CitiusTech, discusses what data interoperability is and what it looks like within a pharmacy context.

Drug manufacturers participating in Medicaid offer lower prices, stretching resources and providing comprehensive services to more patients.

Continuing leadership education can help further develop pharmacy leaders by teaching effective utilization of various power strategies.

While progress is being made to advance the Cures Act, it is essential to ensure pharmacy interoperability given pharmacy’s critical role in health care.